Riskpilot← Back to searchSign inGet full accessPrecision Bioanalytics Sweden AB
ABActiveOrg 5594435132Kärnvedsgatan 67Technical testing and analysis · NACE 7120Est. 20231-4 employees
Revenue 2024
SEK 209K
EBITDA margin
15.8%
Equity ratio
83.9%
Financial strength
Net profit 2024
SEK 19K
| Revenue | SEK 209K | — |
| EBITDA | SEK 33K | — |
| Net profit | SEK 19K | — |
| Total assets | SEK 142K | — |
| Equity | SEK 119K | — |
| Employees | — | — |
Legal name
Precision Bioanalytics Sweden AB
Org number
5594435132
Legal form
Aktiebolag
NACE code
7120 · Technical testing and analysis
Founded
2 augusti 2023
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Utveckling av produkter och tjänster för molekylära analyser och därmed förenlig verksamhet.
Address
Kärnvedsgatan 67
Email
fredrik@adlercreutz.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 209 |
| Staff expenses | — |
| EBITDA | 33 |
| Depreciation & amort. | — |
| EBIT | 33 |
| Net financials | 0 |
| Profit before tax | 25 |
| Tax | −5 |
| Net profit | 19 |
| Item | 2024 |
|---|---|
| Total assets | 142 |
| Equity | 119 |
| Long-term debt | — |
| Short-term debt | 15 |
| Total debt | 15 |
EBITDA margin
15.8%
This company
15.8%
Market median
+0% vs market
20242024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20242024
Return on equity
16.3%
This company
18.4%
Market median
+11% vs market
20242024
Net profit margin
9.3%
This company
8.1%
Market median
+15% vs market
20242024
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20242024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20242024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JJ Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Board of Directors | 2023 – 2023 | |
| Deputy Board Member | 2023 – 2025 | |
| Deputy Board Member | 2023 – 2023 | |
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Precision Bioanalytics Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Joel Björkman | Chief Executive Officer | 0 companies |
| Fredrik Åke Tobias Adlercreutz | Chairman | 0 companies |
| Johan Fredrik Wessberg | Board of Directors | 0 companies |
| Mikael Kubista | Board of Directors | 0 companies |
| Gösta Robert Sjöback | Board of Directors | 0 companies |
| M H Charlotte Wiberg Larsson | Board of Directors | 0 companies |
| Therese Margareta Kristina Lundberg | Deputy Board Member | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |